Cargando…
Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study
Although pregnancy is potentially protective against relapses of multiple sclerosis, severe rebound of disease activity after withdrawal of fingolimod may occur. We report a woman with multiple sclerosis who discontinued fingolimod in the first month of her pregnancy. She developed severe disease re...
Autores principales: | Canibaño, Beatriz, Ali, Musab, Mesraoua, Boulenouar, Melikyan, Gayane, Al Hail, Hasan, Ibrahim, Faiza, Hanssens, Yolande, Deleu, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906717/ https://www.ncbi.nlm.nih.gov/pubmed/31867224 http://dx.doi.org/10.1016/j.crwh.2019.e00162 |
Ejemplares similares
-
Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations
por: Canibaño, Beatriz, et al.
Publicado: (2020) -
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
Publicado: (2018) -
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
por: Novi, Giovanni, et al.
Publicado: (2017) -
Prevalence and Incidence of Drug-Resistant Temporal Lobe Epilepsy in Qatar
por: Mesraoua, Boulenouar, et al.
Publicado: (2020) -
Seizure clusters
por: Mesraoua, Boulenouar, et al.
Publicado: (2021)